User: Guest  Login
Title:

Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) compari

Document type:
Article
Author(s):
du Bois, A; Sehouli, J; Lund, B; Joly, E; Huober, J; Jensen, TS; Levy, E; Heilmann, V; Boman, K; Hardy-Bessard, AC; Burges, A; Maenpaa, J; Pujade-Lauraine, E; Pfisterer, J; Gropp, M; Staehle, A; Wimberger, P; Jackisch, C; Schmalfeldt, B; Belau, A; Loibl, S; Wollschlaeger, K; Canzler, U; Rochon, J
Journal title abbreviation:
Int J Gynecol Cancer
Year:
2005
Journal volume:
15 Suppl.
Pages contribution:
224-225
Language:
eng
Print-ISSN:
1048-891X
TUM Institution:
Frauenklinik und Poliklinik
 BibTeX